Hailong Zhang

Key Laboratory Of Preclinical Study For New Drugs Of Gansu Province, 2019RU066
Lanzhou, 730000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Development and Preclinical Evaluation of the Novel Peptide-Based Tracer 68Ga-PDT01 for Noninvasive PET Imaging of PD-L1 Expression.

Development and Preclinical Evaluation of the Novel Peptide-Based Tracer 68Ga-PDT01 for Noninvasive PET Imaging of PD-L1 Expression.

Journal: Journal of medicinal chemistry

Published: June 01, 2026

A Novel PET/CT Tracer for Human Urokinase-Type Plasminogen Activator Receptor.

A Novel PET/CT Tracer for Human Urokinase-Type Plasminogen Activator Receptor.

Journal: Journal of medicinal chemistry

Published: May 06, 2026

64Cu-Labeled Stapled Peptide-Based Radiopharmaceuticals Targeting MDM2/MDMX for Pan-p53 Tumors.

64Cu-Labeled Stapled Peptide-Based Radiopharmaceuticals Targeting MDM2/MDMX for Pan-p53 Tumors.

Journal: Journal of medicinal chemistry

Published: October 25, 2025

10P3Me: A GPC3-Targeted Peptide PET Probe for Subcutaneous and Orthotopic HCC Imaging.

10P3Me: A GPC3-Targeted Peptide PET Probe for Subcutaneous and Orthotopic HCC Imaging.

Journal: Journal of medicinal chemistry

Published: September 08, 2025

The Mitochondrial Guardian α-Amyrin Mitigates Alzheimer's Disease Pathology via Modulation of the DLK-SARM1-ULK1 Axis.

The Mitochondrial Guardian α-Amyrin Mitigates Alzheimer's Disease Pathology via Modulation of the DLK-SARM1-ULK1 Axis.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: July 03, 2025

Discovery of Cationic Lugdunin Derivatives with Membrane-Disrupting Activity against Resistant Bacteria via Radical Reactions and Amino Acid Mutations.

Discovery of Cationic Lugdunin Derivatives with Membrane-Disrupting Activity against Resistant Bacteria via Radical Reactions and Amino Acid Mutations.

Journal: Journal of medicinal chemistry

Published: February 21, 2025

Development of Cyclic Peptide-Based Radiotracers for uPAR.

Development of Cyclic Peptide-Based Radiotracers for uPAR.

Journal: ChemMedChem

Published: January 22, 2025

A dual-targeting peptide-drug conjugate based on CXCR4 and FOLR1 inhibits triple-negative breast cancer.

A dual-targeting peptide-drug conjugate based on CXCR4 and FOLR1 inhibits triple-negative breast cancer.

Journal: Acta pharmaceutica Sinica. B

Published: January 17, 2025

Fibroblast activation protein targeting radiopharmaceuticals: From drug design to clinical translation.

Fibroblast activation protein targeting radiopharmaceuticals: From drug design to clinical translation.

Journal: Acta pharmaceutica Sinica. B

Published: January 09, 2025

Precise PEGylation Modulates the in Vivo Fate of Peptide Radiopharmaceuticals.

Precise PEGylation Modulates the in Vivo Fate of Peptide Radiopharmaceuticals.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: November 04, 2024

Determining the Multivalent Effects of d-Peptide-Based Radiotracers.

Determining the Multivalent Effects of d-Peptide-Based Radiotracers.

Journal: Chemical & biomedical imaging

Published: September 21, 2024

Spautin-1 promotes PINK1-PRKN-dependent mitophagy and improves associative learning capability in an alzheimer disease animal model.

Spautin-1 promotes PINK1-PRKN-dependent mitophagy and improves associative learning capability in an alzheimer disease animal model.

Journal: Autophagy

Published: July 25, 2024

Showing 1-12 of 19

Last Updated: 09/26/2026